Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122983182 | 12298318 | 2 | F | 2014 | 20160809 | 20160423 | 20160818 | EXP | US-ABBVIE-16K-163-1606927-00 | ABBVIE | 0.00 | F | Y | 68.10000 | KG | 20160818 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122983182 | 12298318 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122983182 | 12298318 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122983182 | 12298318 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122983182 | 12298318 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122983182 | 12298318 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 0 | 5 | MG | QD | |||||||||
| 122983182 | 12298318 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 8 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 122983182 | 12298318 | 12 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122983182 | 12298318 | 1 | Rheumatoid arthritis |
| 122983182 | 12298318 | 5 | Rheumatoid arthritis |
| 122983182 | 12298318 | 6 | Rheumatoid arthritis |
| 122983182 | 12298318 | 7 | Product used for unknown indication |
| 122983182 | 12298318 | 8 | Product used for unknown indication |
| 122983182 | 12298318 | 9 | Hypertension |
| 122983182 | 12298318 | 10 | Product used for unknown indication |
| 122983182 | 12298318 | 11 | Product used for unknown indication |
| 122983182 | 12298318 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122983182 | 12298318 | OT |
| 122983182 | 12298318 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122983182 | 12298318 | Arthralgia | |
| 122983182 | 12298318 | Chondropathy | |
| 122983182 | 12298318 | Drug ineffective | |
| 122983182 | 12298318 | Foot deformity | |
| 122983182 | 12298318 | Gait disturbance | |
| 122983182 | 12298318 | Herpes zoster | |
| 122983182 | 12298318 | Intervertebral disc protrusion | |
| 122983182 | 12298318 | Lumbar spinal stenosis | |
| 122983182 | 12298318 | Neuroma | |
| 122983182 | 12298318 | Osteoarthritis | |
| 122983182 | 12298318 | Pneumonia | |
| 122983182 | 12298318 | Pruritus | |
| 122983182 | 12298318 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122983182 | 12298318 | 1 | 20140306 | 0 | ||
| 122983182 | 12298318 | 2 | 201407 | 201408 | 0 | |
| 122983182 | 12298318 | 3 | 201410 | 201506 | 0 | |
| 122983182 | 12298318 | 4 | 20160324 | 0 | ||
| 122983182 | 12298318 | 6 | 2012 | 0 |